Reverse phase protein array based tumor profiling identifies a biomarker signature for risk classification of hormone receptor-positive breast cancer

In conclusion, the biomarker signature introduced supports RPPA as a tool for cancer biomarker discovery. Graphical abstract
Source: Translational Proteomics - Category: Biomedical Science Source Type: research